Lisa A. Mango - 15 Feb 2023 Form 4 Insider Report for 1Life Healthcare Inc

Role: General Counsel and Secretary
Signature: /s/ Ivy Tseng, Attorney-in-Fact for Lisa A Mango
Issuer symbol: N/A
Transactions as of: 15 Feb 2023
Net transactions value: -$210,860
Form type: 4
Filing time: 17 Feb 2023, 19:46:08 UTC
Previous filing: 05 Jan 2023
Next filing: 24 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONEM	Common Stock	Options Exercise		+11,525	+13%		99,910	15 Feb 2023	Direct	F1
transaction	ONEM	Common Stock	Options Exercise		+2,221	+2.2%		102,131	15 Feb 2023	Direct	F1
transaction	ONEM	Common Stock	Sale	$116,644	-7,596	-7.4%	$15.36	94,535	16 Feb 2023	Direct	F2, F3
transaction	ONEM	Common Stock	Sale	$94,216	-6,150	-6.5%	$15.32	88,385	17 Feb 2023	Direct	F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONEM	Restricted Stock Units	Options Exercise	$0	-11,525	-25%	$0.000000	34,573	15 Feb 2023	Common Stock	11,525		Direct	F1, F6
transaction	ONEM	Restricted Stock Units	Options Exercise	$0	-2,221	-33%	$0.000000	4,441	15 Feb 2023	Common Stock	2,221		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units ("RSUs") convert into the issuer's common stock on a one-for-one basis.
F2	Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the reporting person.
F3	This transaction was executed in multiple trades at prices ranging from $15.31 to $15.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
F5	This transaction was executed in multiple trades at prices ranging from $15.30 to $15.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6	The RSUs vest in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.